Health
Novavax shares jump after Covid vaccine maker posts surprise quarterly profit
Medical syringes and Novavax logo displayed in the background are seen in this illustration photo taken in Krakow, Poland on December 2, 2021. Jakub Porzycki | NurPhoto | Getty Images Shares of Novavax jumped as much as 20% in premarket trading Tuesday after the Covid vaccine maker reported a surprise second-quarter profit. The results come […]
Read More
Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%
Sopa Images | Lightrocket | Getty Images Eli Lilly on Tuesday raised its full-year guidance as second-quarter profit jumped 85% from the same period a year ago on strong sales from the pharmaceutical giant’s drug pipeline. The company now expects full-year revenue of between $33.4 billion to $33.9 billion, up from a previous forecast of […]
Read More
Red Cross ends blood-donation restrictions that singled out gay and bisexual men
A worker with Vitalant places a needle on the arm of a blood donor as he prepares to donate blood during the Hoboken community Vitalant blood drive held at Hoboken Rec Center on June 25, 2021 in Hoboken, New Jersey. Michael M. Santiago | Getty Images The American Red Cross is now allowing gay and […]
Read More
Sage Therapeutics stock plunges more than 50% after FDA denies wider use of postpartum depression drug
In this photo illustration, the Sage Therapeutics logo of a biopharmaceutical company seen on a smartphone and on a pc screen. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Shares of Sage Therapeutics fell more than 50% on Monday after the Food and Drug Administration approved the biotech company’s oral drug zuranolone for […]
Read More
I had a doctor’s visit powered by A.I. — here’s what it was like
Chance are that during your doctor’s appointments these days, your physician is laser-focused on typing notes into a computer while talking with you. They do that to get the clinical information into the electronic health record. But what if artificial intelligence took the notes for them? Doctors and medical professionals who’ve adopted the technology are […]
Read More
How hospitals are using A.I. to fight doctor burnout
When Dr. Tra’chella Johnson Foy greets her patients, she sits across from them facing away from the computer in the exam room. Then, she pulls out her phone, and asks for permission to record the appointment. “It listens in on our visit so I can pay more attention to you,” explains Foy, a family physician […]
Read More
Here are the 5 price-target changes and 4 trades we made during this busy earnings week
In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Many of these moves stemmed from what we saw in quarterly numbers and heard on conference calls. Here’s a day-by-day look at the portfolio action. Monday The week began with our decision to exit […]
Read More
Troubled health name bounces after strong quarter and guidance. Here’s our view on the stock
Troubled Club holding Bausch Health Companies (BHC) reported better-than-expected quarterly results before the bell Thursday. However, it’s not nearly enough to get this stock out of the penalty box. Sales in the second quarter rose 10% to $2.17 billion, exceeding expectations of $2.04 billion, according to estimates compiled by Refinitiv. (On an organic basis — […]
Read More
Infant RSV shot faces final hurdle at CDC, could be available by fall
A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic Moenchberg, in Wuerzburg, Germany, December 2, 2022. Heiko Becker | Reuters Americans may soon have access to a shot that protects babies from respiratory syncytial virus, or RSV, the leading cause of hospitalization among infants in the U.S. A panel […]
Read More
Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales
Artur Widak | Nurphoto | Getty Images Shares of Moderna rose Thursday after the biotech company hiked its full-year outlook for its Covid vaccine, its only marketable product, despite reporting a quarterly loss and sharp drop in revenue. Here are Moderna’s results: Loss per share: $3.62 (That may not be comparable to the $4.04 expected by […]
Read More